BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 26528580)

  • 1. Digital image analysis of AgNORs in cervical smears of women with premalignant and malignant lesions of the uterine cervix.
    García-Vielma C; Dávila-Rodríguez MI; Hernández-Garza F; Cerda-Flores RM; Cortés-Gutiérrez EI
    Biotech Histochem; 2016; 91(2):102-7. PubMed ID: 26528580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of AgNOR counts and morphometric analysis of nuclear parameters in premalignant and malignant lesions of the uterine cervix.
    Wierzchniewska A; Wagrowska-Danilewicz M; Danilewicz M
    Pol J Pathol; 1998; 49(4):297-301. PubMed ID: 10323085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grading cervical dysplasia with AgNORs using a semiautomated image analysis system.
    Bharucha H; McCluggage G; Lee J; Bannister W; Kuan L; Wilhelm P; Nelson A
    Anal Quant Cytol Histol; 1993 Oct; 15(5):323-8. PubMed ID: 8259973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Argyrophilic nucleolar organizer regions (AgNORs) in inflammatory pre-malignant and malignant lesions of the uterine cervix.
    Lahshmi S; Nair SA; Jayasree K; Jayaprakash PG; Rajalekshmy TN; Kannan S; Pillai R
    Cancer Lett; 1993 Jul; 71(1-3):197-201. PubMed ID: 8364893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silver-stained nucleolar organizer regions in normal and dysplastic cervical lesions: correlation with DNA ploidy and S-phase fraction by flow cytometry.
    Singh M; Prasad S; Kalra N; Singh U; Shukla Y
    Oncology; 2006; 71(5-6):411-6. PubMed ID: 17785995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleolar organizer regions in benign and malignant glandular lesions of the cervix.
    Allen JP; Gallimore AP
    J Pathol; 1992 Feb; 166(2):153-6. PubMed ID: 1560315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p16INK4A expression in cervical premalignant and malignant lesions.
    Lambert AP; Anschau F; Schmitt VM
    Exp Mol Pathol; 2006 Apr; 80(2):192-6. PubMed ID: 16257403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of cytological screening for cancers and precancerous lesions of the cervix].
    Boman F; Duhamel A; Trinh QD; Deken V; Leroy JL; Beuscart R
    Bull Cancer; 2003 Jul; 90(7):643-7. PubMed ID: 12957806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-grade squamous intraepithelial lesions and invasive carcinoma following the report of three negative Papanicolaou smears: screening failures or rapid progression?
    Sherman ME; Kelly D
    Mod Pathol; 1992 May; 5(3):337-42. PubMed ID: 1495939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of AgNORS in premalignant and malignant lesions of the cervix.
    Prathiba D; Kuruvilla S
    Indian J Pathol Microbiol; 1995 Jan; 38(1):11-6. PubMed ID: 8919464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do all grade I lesions on colposcopy need to be biopsied?
    Suneja A; Guleria K; Mahishee ; Mishra K; Agarwal N
    Indian J Cancer; 1999; 36(2-4):135-40. PubMed ID: 10921217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From Papanicolaou to Bethesda: the rationale for a new cervical cytologic classification.
    Kurman RJ; Malkasian GD; Sedlis A; Solomon D
    Obstet Gynecol; 1991 May; 77(5):779-82. PubMed ID: 1849626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Precancerous lesions of the uterine cervix in Pointe-Noire, Congo].
    Moukassa D; N'Golet A; Lingouala LG; Eouani ML; Samba JB; Mambou JV; Ompaligoli S; Moukengue LF; Taty-Pambou E
    Med Trop (Mars); 2007 Feb; 67(1):57-60. PubMed ID: 17506275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AgNOR counts in cervical smears under normal and other cytopathologic conditions.
    Misra JS; Das V; Srivastava AN; Singh U; Singh M
    Anal Quant Cytol Histol; 2005 Dec; 27(6):337-40. PubMed ID: 16450790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferative activity in squamous intraepithelial and invasive lesions of cervix: analysis by AgNOR staining.
    Pahuja S; Choudhury M; Gupta U
    Indian J Pathol Microbiol; 2003 Oct; 46(4):573-5. PubMed ID: 15025346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocytochemical staining of cervical smears for the diagnosis of cervical intraepithelial neoplasia.
    Moncrieff D; Ormerod MG; Coleman DV
    Anal Quant Cytol; 1984 Sep; 6(3):201-5. PubMed ID: 6391321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dynamics of keratin expression in malignant transformation of cervical epithelium: a review.
    Smedts F; Ramaekers FC; Vooijs PG
    Obstet Gynecol; 1993 Sep; 82(3):465. PubMed ID: 7689193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda System.
    Syrjänen K; Kataja V; Yliskoski M; Chang F; Syrjänen S; Saarikoski S
    Obstet Gynecol; 1992 May; 79(5 ( Pt 1)):675-82. PubMed ID: 1314359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silver-stained nucleolar organizer regions and immunoglobulins in cutaneous squamocellular tumors.
    Aroni K; Mastoraki A; Kyriazi E; Liossi A; Ioannidis E
    Pathol Res Pract; 2007; 203(12):857-62. PubMed ID: 17949923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease.
    Simpson KL; Jones A; Norman S; Holmes CH
    Am J Pathol; 1997 Nov; 151(5):1455-67. PubMed ID: 9358772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.